Richard Band
Richard Band (RSS)
Editor, Profitable Investing

Richard Band is editor of Profitable Investing, a value-oriented advisory service designed to help long-term investors achieve their growth and income goals safely and systematically. Richard's straightforward style and low-risk "value" approach to wealth building have won nine awards in the "Best Financial Advisory" category from the Specialized Information Publishers Foundation (formerly the Newsletter and Electronic Publishers Foundation).

Read complete bio
Recent Articles

Markets Back In Familiar Territory

Nov. 4, 2015, 11:45 am EST – Despite continued problems in China and slow economic news, markets continue to roll along, headed back towards a record high More 

Merck: The Smart Way to Buy Into Healthcare (MRK)

Nov. 2, 2015, 12:40 pm EST – Merck is the very definition of big pharma – and solid growth, especially through good use of M&A. More 

Time to Update Microsoft, GE and More (MSFT, GE, DUK, PNY, ABBV)

Oct. 28, 2015, 2:15 pm EST – Markets continue to reward stocks with strong earnings, and in some cases those making news. Here's an update on 5 stocks from both sides More 

INGN: A Breath of Fresh Air

Oct. 23, 2015, 11:22 am EST – This niche player has cornered the market in an important healthcare sector. More 

Wally’s Stunner Is No Reason to Leave Wal-Mart Stock (WMT)

Oct. 22, 2015, 11:30 am EST – WMT's recent earnings disappointment and forecast caught many by surprise, but Wal-Mart stock is still a long-term buy More 

Two-Way Traffic Again for Investors

Oct. 21, 2015, 11:00 am EST – With the recent rally starting to flatten out, it's time for investors to look at not only new buys, but also selling opportunities. More 

Bullish Dividends? Bearish Drama? Choose VNQ

Oct. 16, 2015, 12:50 pm EST – If you would prefer to stop worrying about volatility, this REIT ETF is a great choice. More 

This Indicator Says Don’t Bail Out of the Market Too Soon

Oct. 14, 2015, 11:30 am EST – Tuesday's market pullback isn't a sign for investors to take out their money. In fact, one indicator suggests investors stay invested More 

ABBV: A Great Way to Play Healthcare’s Comeback

Oct. 8, 2015, 2:58 pm EST – AbbVie's Humira is soon to be the world's No. 1 best-selling drug. And its growth prospects couldn't look better. More 

Time for Markets to Rally On — Maybe (ABBV, JNJ, MCD)

Oct. 7, 2015, 10:30 am EST – Several recent rallies in the markets have investors seeing positive signs moving forward, although doubts remain. Here is where I stand. More